Looking for the next apple? This is the orchard.
|
|
|
|
|
Join FAT Brands (FAT) CEO Andrew Wiederhorn at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Andrew to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
|
|
|
|
|
Join Idaho Champion Gold (GLDRF) CEO Jonathan Buick at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Jonathan to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
|
|
|
|
|
Join Information Services Group (III) CFO David Berger & CEO Michael Conners at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join David and Michael to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
District Scale Property Currently Being Developed by Gold Standard Ventures
Vancouver, British Columbia, Canada, January 11, 2021. Ely Gold Royalties Inc. (TSXV: ELY, OTCQX: ELYGF) (“Ely Gold” or the “Company”) is pleased to announce that on December 30, 2020 it closed the purchase of private mineral interests on over 8,000 acres of private fee ground in Elko County, Nevada (the “Mineral Interests”).
All the fee ground and the Mineral Interests are currently leased to Gold Standard Ventures Corp (NYSE AMERICAN: GSV, TSX: GSV) (“GSV”) and cover certain portions of GSV’s Railroad-Pinion Project currently being developed as a heap-leach mining operation (the “Lease”). The Lease provides for a combined 0.436% net smelter returns royalty (“NSR”) and annual lease payments of US$79,800 (the “OR Transaction”). The Mineral Interests and Leases cover large portions of the Pinion, Dark Star, Jasperoid Wash deposits in the South Railroad Complex as well as portions of the POD and Bald Mountain zones in the North Railroad (see Figure 1). The Company first announced the OR Transaction in a press release dated November 2, 2020 (the 11/2/2020 Press Release”)
The OR Transaction
Ely Gold paid total consideration of US$1,300,000 cash and issued 300,000 common stock warrants (the “Ely Warrants”) for the OR Transaction. The Ely Warrants have a five-year term and will have an exercise price of CDN$1.14. Securities issued under the Ely Warrants will be subject to a four-month hold period. In connection with its assistance with both transactions, Ely Gold has paid a cash finder’s fee to R&R Land, Mineral & Oil LLC (R&R) totaling US$65,000.
The ORTT Transaction
The 11/2/2020 Press Release also included the acquisition of additional mineral interests and leases (the “ORTT Transaction”) for total payment of US$2,509,543 cash. The ORTT Transaction included leases that provided for a 0.71% NSR as well as annual advance royalty payments. After further due diligence and lastminute negotiations by certain owners, Ely Gold has opted to terminate the ORTT Transaction. Ely Gold has paid R&R a break fee of US$134,000 in connection with this termination.
Railroad-Pinion Project
The Railroad-Pinion Project is an advanced stage gold project with a favorable structural, geological and stratigraphic setting situated at the southeast end of the Carlin Trend of north-central Nevada, adjacent to and south of Nevada Gold Mines’ Rain Mining District.
On February 18, 2019, Gold Standard announced an updated Pre-Feasibility Study for The South Railroad portion of the Railroad-Pinion project consisting of the Dark Star deposit and the Pinion Deposit. Key Highlights of the Updated Base Case South Railroad PFS include: (all currencies are shown in US dollars):
Details of the Pre-Feasibility study can be found in Form 43-101F1 Technical Report Updated Preliminary Feasibility Study Elko County, Nevada at the following link:
https://goldstandardv.com/site/assets/files/4408/m3_gsv_revised_pfs_23_03_2020.pdf
On July 16, 2020 GSV announced the entering into a binding letter of intent with Orion Mine Finance relating to a series of transactions, totaling approximately US$22.5 million, including a term sheet to provide up to US$200 million of financing support to GSV, to help finance the construction of the South Railroad Project.
On December 2, 2020 and January 5, 2021, GSV announced the appointment of new senior management with strong experience in Capital Markets and mine development and construction.
On November 12, 2020 GSV announced encouraging drill results from 24 of 75 holes in the 2020 Pinion deposit development program. Oxide results include:
42.7m of 0.92 g Au/t, including 7.6m of 2.69 g Au/t in hole PR20-14; 38.1m of 0.97 g Au/t in PR20-15;
64.0m of 0.81 g Au/t, including 22.9m of 1.20 g Au/t in hole PR20-19; and 29.0m of 0.77 g Au/t, including 12.2m of 1.28 g Au/t in PR20-23.
Objectives of the 2020 Pinion development program include: 1) decreasing drill spacing on the Pinion Phase 4 ($1400 pit) inferred oxide resource for potential conversion to Measured and Indicated; 2) provide material for metallurgical testing; and 3) tighten the drill spacings near historic Cameco holes SB-136, an RC hole that intersected 102.1m of 1.38 g Au/t, and SB-162-99, a core hole that twinned and verified theSB-136 results with an intercept of 112.0m of 1.24 g Au/t.
On November 18, 2020, GSV released results from six holes targeting and intersecting up-dip, near-surface oxide mineralization to the east of GSV’s drilling at Main Dark Star Deposit. The results from step out holes DR20-01 through DR20-06 intersected thick intervals of oxide mineralization to the east of the existing GSV drilling at Main Dark Star including hole DR20-02 that intersected 61.0m of 0.66 g Au/t including 24.4m of 1.03 g Au/t. This mineralization begins at the current topographic surface and remains open to the east along a strike length of approximately 330m. These results indicate the possibility to expand the Main Dark Star deposit to the east with low strip up front ounces during early production.
All drill holes in the 2020 Pinion & Dark Star Main development programs are located on the Mineral Interests being purchased by Ely Gold. (see Figure 2)
Mineral Interests & Leased Claims
Figure 1
GSV Expansion Drilling
Figure 2
Qualified Person
Stephen Kenwood, P. Geo, is director of the Company and a Qualified Person as defined by NI 43-101. Mr. Kenwood has reviewed and approved the technical information in this press release.
About Ely Gold Royalties Inc.
Ely Gold Royalties Inc. is a Nevada focused gold royalty company. Its current portfolio includes royalties at Jerritt Canyon, Goldstrike and Marigold, three of Nevada’s largest gold mines, as well as the Fenelon mine in Quebec, operated by Wallbridge Mining. The Company continues to actively seek opportunities to purchase producing or near-term producing royalties. Ely Gold also generates development royalties through property sales on projects that are located at or near producing mines. Management believes that due to the Company’s ability to locate and purchase third-party royalties, its strategy of organically creating royalties and its gold focus, Ely Gold offers shareholders a favourable leverage to gold prices and low-cost access to long-term gold royalties in safe mining jurisdictions.
On Behalf of the Board of Directors
Signed “Trey Wasser”
Trey Wasser, President & CEO
For further information, please contact:
Trey Wasser, President & CEO
trey@elygoldinc.com
972-803-3087
Joanne Jobin, Investor Relations Officer
jjobin@elygoldinc.com
647 964 0292
FORWARD-LOOKING CAUTIONS: This press release contains certain “forward-looking statements” within the meaning of Canadian securities legislation, including, but not limited to, statements regarding completion of the Transaction. Forwardlooking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “aims,” “potential,” “goal,” “objective,” “prospective,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Except to the extent required by applicable securities laws and the policies of the TSX Venture Exchange, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change. Factors that could cause future results to differ materially from those anticipated in these forward-looking statements include the Company’s inability to control whether the buy-down right will ever be exercised, and whether the right of first refusal will ever be triggered, uncertainty as to whether any mining will occur on the property covered by the Probe Royalty such that the Company will receive any payment therefrom, and the general risks and uncertainties relating to the mineral exploration, development and production business. The reader is urged to refer to the Company’s reports, publicly available through the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com for a more complete discussion of such risk factors and their potential effect.
Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Source: Ely Gold Royalties
Submits formal response to the U.S. Food and Drug Administration’s request for additional information
NEWTOWN, Pa., Jan. 11, 2021 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that it has submitted its formal response to the U.S. Food and Drug Administration’s (the “FDA” or “Agency”) request for additional information.
The FDA’s request for additional information was related to the Company’s request for de novo classification and clearance of the Portable Neuromodulation Stimulator (PoNS™) device as a potential treatment for gait deficit due to symptoms of Multiple Sclerosis (“MS”), to be used as an adjunct to a supervised therapeutic exercise program in patients over 18 years of age.
“The Helius team is very excited to announce the timely submission of our response to the FDA’s request for additional information,” said Dane Andreeff, Interim President and Chief Executive Officer of Helius. “The achievement of this important milestone was made possible by the diligent efforts of our regulatory and clinical affairs team, and I would like to thank them for their hard work and dedication in recent months.”
Mr. Andreeff continued: “Looking ahead, we expect that the FDA’s receipt of our response will enable the FDA to resume its review of our request for de novo classification and clearance. We remain committed to our goal of bringing our PoNS technology to the aid of U.S. patients suffering with gait deficit due to MS-related symptoms as expeditiously as possible, and hope to receive the FDA’s decision on our request for de novo classification and clearance during the first half of this year.”
Additional Background Information:
Helius submitted its request for de novo classification and clearance of the PoNS device for the treatment of gait deficit due to symptoms from MS on August 4, 2020, following the receipt of Breakthrough Designation by FDA in early May. On October 19, 2020, the Company announced the receipt of the FDA’s request for additional information, which was received approximately 75 days following the submission date and placed the FDA’s review on hold until receipt by the FDA of the requested information.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNSTM). For more information, visit www.heliusmedical.com.
About the PoNS™ Device and PoNS Treatment™
The Portable Neuromodulation Stimulator (PoNS™) is authorized for sale in Canada as a class II, non-implantable, medical device intended as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from multiple sclerosis (MS), and chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy. The PoNS™ is an investigational medical device in the United States, the European Union (“EU”), and Australia (“AUS”). The device is currently under review for de novo classification and clearance by the FDA. It is also under premarket review by the AUS Therapeutic Goods Administration. PoNS™ is currently not commercially available in the United States, the European Union or Australia.
Investor Relations Contact:
Westwicke Partners on behalf of Helius Medical Technologies, Inc.
Jack Powell
investorrelations@heliusmedical.com
Cautionary Disclaimer Statement:
Certain statements in this news release are not based on historical facts and constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements other than statements of historical fact included in this news release are forward-looking statements that involve risks and uncertainties. Forward-looking statements are often identified by terms such as “believe,” “continue,” “look forward,” “will,” “committed to,” “goal,” “expect,” “remain,” “hope” and similar expressions. Such forward-looking statements include, among others, statements regarding the Company’s future growth and operational progress, clinical and regulatory development plans for the PoNS device, and potential regulatory clearance of the PoNS device, including expected timing for the FDA to resume its review of our request for de novo classification and clearance and expected timing for receipt of the FDA’s decision on such request.
These statements involve substantial known and unknown risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those expressed or implied by such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include uncertainties associated with the clinical development process and FDA regulatory submission and approval process, including that the Company’s request for de novo classification and clearance may be declined by the FDA, that the FDA is not required to and may not respond to the Company’s request in the timeframe indicated by its de novo review goals or in the time the Company expects, whether the Company’s response will be satisfactory to the FDA, whether the FDA will require additional information, whether the Company will be able to provide it in a timely manner and whether such additional information will be satisfactory to the FDA, uncertainties regarding the Company’s capital requirements to achieve its business objectives, the impact of the COVID-19 pandemic, uncertainties associated with future clinical trials and other development activities, and other risks detailed from time to time in the filings made by the Company with securities regulators, including the risks and uncertainties described in the “Risk Factors” sections of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 and its other filings with the United States Securities and Exchange Commission and the Canadian securities regulators, which can be obtained from either at www.sec.gov or www.sedar.com.The reader is cautioned not to place undue reliance on any forward-looking statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company assumes no obligation to update any forward-looking statement or to update the reasons why actual results could differ from such statements except to the extent required by law.
The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
SOURCE: Helius Medical Technologies
|
|
|
|
|
Join Playboy CEO Ben Kohn at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Ben to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
|
|
|
|
|
Join Seanergy (SHIP) CEO Stamatis Tsantanis & CFO Stavros Gyftakis at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Stamatis and Stavros to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
|
|
|
|
|
Join Cocrystal (COCP) CEO Gary Wilcox at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Gary to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
The U.S. dollar has been declining in value since late Spring 2020. Although other newsworthy trends may have taken exchange rates out of the spotlight; a new year is usually a time when investors readjust their focus. The change of economic priorities in Washington also signals investors to consider readjusting their radar to find investment opportunities with higher likelihood of success. Should the declining $US Dollar trend continue it may turn out to have a sizeable impact on asset prices in various sectors during 2021.
The last time equity investors paid much attention to currency valuation was 2011. For the benefit of readers in the market for less than 10 years, we’ll quickly recap some basics such as: What is a weak dollar? Why is the dollar weak? And then move to the important question, what industries may benefit from a weak dollar?
Weak Dollar
Supply and demand of a currency cause it to move higher and lower based on demand, assuming a stable money supply. If demand for either goods or financial assets priced in a currency rise, it exerts upward pressure on the currency’s value. For example, consider oil demand since the COVID slowdown. Most oil is purchased on global markets in $US Dollars. If worldwide economic activity slows and there are fewer barrels being purchased, there is a lower demand for dollars to exchange for crude oil. This lower demand helps depress the currency’s value. Another common example is interest rates. Currencies will be exchanged in order to buy notes of a country that has higher yields net of native inflation (after adjusting for sovereign risk). This is why rising real U.S. interest rates vs. other nations ordinarily coincide with a strengthening dollar — lower rates have the opposite effect.
Since the 1980s money supply has mostly had a gentle upslope that steepened some starting in 2008. As mentioned above, an increase of supply of something without an offsetting increase in demand places downward pressure on the value of it (in this case the $USD). There has been an abrupt increase in the supply of money in circulation in recent months. The graph below of money supply (M1) shows the dramatic increase in currency.
Money Supply (M1) Since January 2000
Source: St. Louis Federal Reserve Bank
Although there are many factors that come into play when the push and pull of markets determine the price for anything, the two key economic ingredients remain supply, which has measurably increased, and demand which is slack because of artificially low rates and a slow world economy.
Impact on Stocks
As the pandemic fears lift and the cabin-fever of individuals from all over the globe help them decide they need a change of scenery, there will be interest in traveling to where their local currency goes the farthest. This makes travel and tourism companies located in the U.S. interesting as an investment. There’s potential for them to have the double benefit of increased overall travel and a weaker dollar steering international travelers to the U.S. Another industry with multiple tailwinds is entertainment. An interesting subset of entertainment is esports which has been enjoying growth in popularity since even before the lockdowns. Esports games know few boundaries for attracting audiences. As a result, many companies are not U.S. based, some of those publicly traded esports related companies that are may get an additional boost if the declining dollar trend continues.
Natural resource stocks are worth watching as well. If it comes out of the ground in the U.S. or a country with a closely correlated currency and is sold abroad someplace with a strong rising currency, the producer could experience higher profits on the same amount of work. Examples include mining of commodities used for building materials such as copper, silver, steel, etc. Any mine operations transacting in U.S. dollars or a correlated currency may get an added currency kicker.
When it comes to asking who benefits from a weaker dollar, one can’t ignore large multinationals. Whether the company does most of its manufacturing in the states and exports those products, or has production facilities across the globe, if sales in a strong currency and converted back to a weaker dollar the company benefits. Larger companies received a great deal of attention last year. Conversely, it would make sense for investors to exercise caution and spend extra time analyzing companies that import a lot of materials or offshore labor. As many of these companies’ stocks have experienced a strong 2020. Investors may prefer instead to determine the smaller suppliers of these large companies that are not as visible, yet benefitting.
While building a watch list for 2021, companies that import from nations experiencing strong currency gains versus the dollar may add have an added consideration as to upward potential.
Take-Away
There is no guarantee that the dollar will continue on its weaker trend. However, the ingredients that cause a weakening dollar seem to be heavily baked into the economic cake. The most recent stimulus may have even turned up the temperature higher by adding to the supply of cash in circulation.
It’s important to note that a strengthening or weakening dollar does not necessarily suggest a strong or weak stock market, it does however suggest sector rotation. The sectors with the higher probabilities of benefitting are those involved in exporting goods or in the case of entertainment, providing a service. The stocks that should be analyzed with the most caution are U.S. manufacturers that rely heavily on imports from countries with inflated currencies.
Paul Hoffman
Managing Editor, Channelchek
Suggested Reading:
Metals and Mining Industry Report, Jan. 4, 2021
US Debt as a Percentage of GDP Skyrocketing
Are you subscribed to Channelchek’s active YouTube channel?
Sources:
How
the Dollar Impacts Commodity Prices
|
|
|
|
|
Join Avivagen (VIVXF) CEO Kym Anthony at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Kym to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
|
|
|
|
|
Join Eagle Bulk Shipping (EGLE) CEO Gary Vogel & CFO Frank De Costanzo at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Gary and Frank to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
|
|
|
|
|
Join Vista Gold (VGZ) CEO Frederick Earnest at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Frederick to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
|
|
|
|
|
Join Genprex (GNPX) CEO Rodney Varner at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 19&20, 2021. Following a formal presentation, a seasoned Wall Street research analyst will join Rodney to moderate a LIVE Q&A session. If you want to be added to the roster of presenters… or if you would like to join the virtual audience of investors, at no cost, go to nobleconference.com. NobleCon 17 Complete Presenting Company Schedule
|
